Explorer les evidences

7,3 per_100_person-yearsHBsAg seroconversion incidence among regular blood donors in Abidjan decreased from 7.3 per 100 person-years in 1992–1994 to 0.2 per 100 person-years in 2010–2012.

Côte d'Ivoirehépatite Bobservé 1992–1994publié 2018Open forum infectious diseaseseurope_pmcdocument de 12 observations

75 /mm³Among hospitalized HIV-positive adults in West Africa, the median CD4 count was 75/mm³.

Côte d'IvoireVIH/sidaobservé 2010publié 2014Journal of the International AIDS Societyeurope_pmcdocument de 22 observationsDOI 10.7448/ias.17.1.18797

17,7 %The median rate of loss to follow-up was 17.7%.

Côte d'IvoireVIH/sidapublié 2010Le Mali medicaleurope_pmcdocument de 17 observations

20 %Mortality in adults admitted to hospital living with HIV was 20%.

Côte d'IvoireVIH/sidapublié 2015The lancet. HIVeurope_pmcdocument de 8 observations

37 %Of the 19 isolated TB strains from inmates at the Correctional and Detention Facility of Abidjan, 7 (37%) had multi-drug resistant TB.

Côte d'Ivoiremulti-drug resistant TBobservé 2015publié 2017PloS oneeurope_pmcdocument de 8 observations

65 %Syndrome of pure meningeal irritation was present in 65% of patients with cryptococcal meningitis.

Côte d'Ivoireméningite cryptococciqueobservé 2008 to 2011publié 2017Journal de mycologie medicaleeurope_pmcdocument de 11 observations

The highest malaria cases’ prevalence was observed in children under 5 years of age.

Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations

1,2 %At month 6, 1.2% of HIV-1-infected adults on zidovudine + lamivudine + efavirenz were dead.

Côte d'IvoireVIH/sidaobservé month 6publié 2006Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 9 observationsDOI 10.1097/01.qai.0000219777.04927.50

1 patientDuring 34 months of follow-up, one patient (1.6%) had third-line treatment.

Côte d'IvoireVIH/sidaobservé 34 monthspublié 2010Le Mali medicaleurope_pmcdocument de 17 observations

0,9 sensitivityqHBsAg levels ≤ 10 IU/mL at month 12 had sensitivity of 0.90 and specificity of 1.00 for predicting HBsAg seroclearance.

Côte d'Ivoirehépatite Bobservé month 12publié 2016Journal of gastroenterology and hepatologyeurope_pmcdocument de 11 observationsDOI 10.1111/jgh.13156

465 /mm3The median pre-antiretroviral treatment CD4 count was 465 cells per cubic millimeter among 1013 patients in the Temprano trial conducted in Côte d'Ivoire.

Côte d'IvoireVIH/sidapublié 2022BMC infectious diseaseseurope_pmcdocument de 3 observationsDOI 10.1186/s12879-022-07082-2

0,6 %At 10 years, scale-back strategies increase projected HIV deaths by 0.6% to 39.1%.

Côte d'IvoireVIH/sidaobservé 10 yearspublié 2017Annals of internal medicineeurope_pmcdocument de 6 observations

2,8 %Arterial thrombosis was found in 1 out of 36 HIV-infected patients, representing 2.8%.

Côte d'Ivoirearterial thrombosis · VIH/sidaobservé January 2005-July 2015publié 2018The Pan African medical journaleurope_pmcdocument de 9 observations

60 patientsOnly 60 AEB patients completed one actual month of antiretroviral treatment.

Côte d'IvoireVIH/sidaobservé January 2000 to December 2005publié 2007Medecine et maladies infectieuseseurope_pmcdocument de 11 observations

6,8 per_100_person-yearsIn a cohort of HIV-infected patients of sub-Saharan African origin, the incidence of lipodystrophy was 6.8 per 100 person-years of follow-up after 3 years of combined antiretroviral therapy.

Côte d'Ivoirelipodystrophy · VIH/sidapublié 2015AIDS research and human retroviruseseurope_pmcdocument de 7 observations

38 %Among 823 hospitalized HIV-positive adults in West Africa, 38% died during hospitalization.

Côte d'IvoireVIH/sidaobservé 2010publié 2014Journal of the International AIDS Societyeurope_pmcdocument de 22 observationsDOI 10.7448/ias.17.1.18797

26,5 hoursThe average delay of consultation after AEB was 26.5 hours, ranging from 1 to 240 hours.

Côte d'Ivoireaccidental exposure to bloodobservé January 2000 to December 2005publié 2007Medecine et maladies infectieuseseurope_pmcdocument de 11 observations

4,3 aORHIV infection was associated with cervical cancer (aOR 4.3 [CI 2.2-8.3]).

Côte d'Ivoirecancer du col de l'utérus · VIH/sidapublié 2015Cancer epidemiologyeurope_pmcdocument de 7 observations

5,8 yearsParticipants in the Temprano ANRS 12136 posttrial phase had a median follow-up duration of 5.8 years.

Côte d'IvoireVIH/sidapublié 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 6 observations

40 %A Bti-based larviciding intervention reduced malaria case prevalence by 40% in community cross-sectional surveys.

Côte d'IvoirepaludismeHAL · Unilimdocument de 54 observations

7,9 odds_ratioCervical cancer was associated with HIV infection with an odds ratio of 7.9.

Côte d'Ivoirecancer du col de l'utérus · VIH/sidapublié 2012PloS oneeurope_pmcdocument de 7 observationsDOI 10.1371/journal.pone.0048108

73 525 individualsThe study included 73,525 ART-naïve PLHIV-1 adults aged >16 years initiating ART.

Côte d'IvoireVIH/sidapublié 2018HIV/AIDS (Auckland, N.Z.)europe_pmcdocument de 7 observations

0,5 per_100_person_weeksMalaria incidence rates remained below 0.5 cases per 100 person-weeks in the >18-year-old age group.

Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations

6 %Thirteen (6%) of patients in the efavirenz group experienced AIDS-defining illnesses.

Côte d'IvoireAIDS-defining illnessespublié 2021The Lancet. Infectious diseaseseurope_pmcdocument de 11 observationsDOI 10.1016/s1473-3099(20)30869-0

70,2 %Most of the treatment-naïve patients (70.2%) had CD4-T cell count ≥500 cells/mm3.

Côte d'IvoireVIH/sidaobservé 2012publié 2015PloS oneeurope_pmcdocument de 9 observations